Investor profile

Lauxera Growth II

Lauxera Capital Partners SAS · France

Investment focus

Start with the fit.

Lauxera Growth II is a healthtech growth-equity fund managed by Lauxera Capital Partners, a firm with offices in Paris and San Francisco. It closed at EUR 520 million in 2026 and writes EUR 20-50 million tickets into 12 to 15 commercial-stage healthtech companies across medical devices, digital health, diagnostics and life-science tools, with a focus on US and global expansion. Early investments include Germany's Acandis and Sweden's Antaros Medical.

Reported EIF strategy: Growth and expansion

AI Connector · MCP

Bring EUACC into your AI.

Choose your AI and follow the walkthrough. Your free EUACC account connects the two.

Illustrated walkthrough

Add EUACC to Claude

In Claude, open Customize, then Connectors.
Click + Add, then Add custom connector.
Name it EUACC, paste the link and click Continue.
Review the detected authentication settings and click Continue. Choose Sign in now, then Register automatically under OAuth client.
Click Add, then sign in with your free EUACC account and approve access.

Connector URLhttps://www.euacc.ai/api/mcp

Works on every Claude plan, including Free (one custom connector). On Team and Enterprise, an Owner adds it.

On a phone, add it at claude.ai in your browser. It then shows up in the Claude app the next time you sign in.

Once connected, try this

Use EUACC to explore “Lauxera growth ii” (https://www.euacc.ai/investors/lauxera-growth-ii). Help me assess investor fit and prepare questions using the available fund profiles. Cite the available sources and flag missing or outdated information.

Your side of the introduction

Give investors a profile worth opening.

List your startup →